Chemonucleolysis with chymopapain: results in 150 patients
- 1 August 1987
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 67 (2), 187-191
- https://doi.org/10.3171/jns.1987.67.2.0187
Abstract
✓ Chemonucleolysis with chymopapain has been advocated for the treatment of lumbar disc disease. When polled by a mail questionnaire, 150 consecutive patients who had undergone chemonucleolysis reported an overall success rate of only 40% and a failure rate of 60%. However, 57% of the patients were active or had only mild restriction of daily activities. Of those patients employed prior to injection, only 63% had returned to work. Those with workmen's compensation benefits fared considerably worse than those covered by third-party insurance (17% vs. 51% success). These results cast doubt on the long-term benefits of chymopapain in the treatment of lumbar disc disease.Keywords
This publication has 29 references indexed in Scilit:
- Surgical Findings and Results of Surgery After Failure of ChemonucleolysisSpine, 1985
- The Chymopapain Clinical TrialsNeurosurgery, 1985
- Efficacy of chymopapain chemonucleolysisJournal of Neurosurgery, 1985
- Multiple cerebral hemorrhages following chymopapain chemonucleolysisJournal of Neurosurgery, 1984
- Late results of treatment of intervertebral disc disease with chymopapainJournal of Neurosurgery, 1983
- Treatment of lumbo-ischialgias of different origins by intradiscal injection of chymopapain (discolysis)Acta Neurochirurgica, 1982
- ChemonucleolysisPublished by Wolters Kluwer Health ,1980
- Chymopapain: a case study in federal drug regulationPublished by American Medical Association (AMA) ,1978
- Forum: ChymopapainSpine, 1977
- Double-blind evaluation of intradiscal chymopapain for herniated lumbar discsJournal of Neurosurgery, 1976